Newsroom | 60933 results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Brightseed, Inc., the AI-native life sciences company, today announced the launch of its innovation platform — the first continuous, AI-powered health sciences innovation platform designed to increase the probability of commercial success across health and life sciences. With this launch, Brightseed formally evolves from a discovery-focused bioactives company into a platform-based enterprise AI company delivering data-as-a-service (DaaS) to global h...

HOLLYWOOD, Fla.--(BUSINESS WIRE)--StarLIMS has agreed to acquire the MODA® Platform, a trusted solution for manufacturing quality assurance and control in regulated environments. The transaction is expected to close in Q2 2026, subject to customary closing conditions. StarLIMS is a leading provider of enterprise laboratory informatics software. The acquisition of the MODA® Platform from Lonza, one of the world’s largest contract development and manufacturing organizations, will enable StarLIMS...

ATLANTA--(BUSINESS WIRE)--New Rithum report, The New Discovery Engine: How consumers are using AI to find, trust, and choose brands, and what's at risk for those they miss...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today shared the first clinical results from two of its siRNA programs for neuromuscular diseases. Early results from Phase 1/2 ascending dose studies of SRP-1001 for facioscapulohumeral muscular dystrophy type 1 (FSHD1) and SRP-1003 for myotonic dystrophy type 1 (DM1) demonstrated dose- dependent muscle exposure, early biomarker effects, and favorable tolerab...

LEXINGTON, Mass.--(BUSINESS WIRE)--TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused on advancing a target-first and proximity-first molecular glue discovery platform to address difficult to drug disease targets, today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for TRI-611, an investigational molecular glue degrader therapy for the treatment of anaplastic lymphoma kinase–positive (ALK+) non-small cell lung cancer (NSCL...

PALO ALTO, Calif.--(BUSINESS WIRE)--Countable Labs achieves CE marking for its Countable 4 Platform, bringing innovative, single-molecule, counting-based PCR to European markets....

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies will host a webinar on April 8 with leading pulmonologists who will share their clinical experience with CyPath Lung....

FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today reported financial results for the eight months ended December 31, 2025, and provided a corporate update. As previously announced, the Company changed its fiscal year from ending April 30 of each year to ending December 31 of each year. There was an eight-month transition period from May 1, 2025 to December 31, 2025 and these results are presented within the condensed consolidated finan...

TOKYO--(BUSINESS WIRE)--Space Quarters Inc. has successfully conducted aircraft-based demonstration tests of space welding for metals and lunar regolith-based construction materials under space-equivalent ultra-high vacuum and simulated microgravity and lunar gravity. Under conditions comparable to construction in space, the company confirmed sound joints and sufficient bonding strength. Space Welding Demonstration through Aircraft-Based Testing A high-vacuum chamber was mounted on an aircraft...

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2026 financial results after the market close on Wednesday, April 22, 2026. The Company will host a conference call the following morning, Thursday, April 23, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you jo...